People often ask: Why invest in gold instead of the stock market or other assets?
Here’s the thing; successful investing always comes down to one fundamental principle: scarcity.
You want to put your money into assets that are limited in supply and not easily reproduced.
Take gold, for example.
The global supply of gold grows at a very modest rate, about 2 to 3% annually. This slow growth is what makes gold valuable.
It’s rare, it’s real, and it can’t be created at the push of a button.
Bitcoin shares a similar trait. There will only ever be 21 million Bitcoins.
Period.
No government or institution can change that. That’s precisely why people are drawn to it.
The same logic applies to high-quality art, profitable and solvent companies, or other assets that are scarce and difficult to replicate.
But here’s something truly fascinating that’s happening in today’s economy, especially relevant for economics students: In most markets, as the price of a good increases, demand decreases. That’s Econ 101.
Yet with gold, we’re seeing the opposite.
Demand for gold is increasing as its price rises.
Gold is starting to behave like a Giffen good, a type of product where demand increases as price rises.
This is typically seen in essential products like rice or bread.
When these products go up in price, people often buy more of them because they can't afford alternatives. They become more necessary as other options become out of reach.
And now, gold is acting the same way, except it’s not the poor who are buying. It’s the central banks.
Let that sink in.
Central banks, which traditionally hold massive amounts of Treasury bonds, are selling off those bonds, even though the dollar has dropped roughly 8% this year.
In the past, they would have bought more bonds when the dollar weakened, but now, they’re doing the opposite. They’re selling, and they’re taking losses.
So what do they do with the money from those losses?
They’re buying gold.
Central banks are shifting strategy. They’re buying gold because they know it’s a hedge. It’s scarce. It’s real. And it holds value when other things don’t.
All roads lead to liquidity and gold.
The moment that liquidity dries up, that’s when you need to start to worry.
So keep your eyes on the liquidity.
Follow where the money is going. And don’t ignore the quiet signal coming from the world’s most powerful financial institutions.
They’re betting on gold. Maybe you should, too.
#Gold #GGP #GEO
$PRME drops its CGD program.
Days later, the FDA unveils the National Priority Review Voucher program.
Now Prime says it’s in “regulatory conversations.”
Doesn’t sound like a pivot, sounds like a setup.
Only 5 vouchers will be awarded.
Is Prime positioning to grab one?🤔
#GEO
Drill countdown: just a few weeks left.
Market’s asleep now, but once that bit turns, watch the volume and price skyrocket.
50+ pre-drill wouldn’t surprise me.
Post-drill? If results hit, this flies.
Callum’s not thinking small.
Neither should you.
#GEO Callum Baxter doesn’t play games.
If Juno’s put a drill date out there, it’s because they know they can deliver.
His reputation is on the line and now it’s tied to JUNO.
RNS could land any day.
Drilling by end of Q3.
Then it gets real. ⛏️👀 #JUNO
$ASTS
The same clowns whining about dips now were trash-talking at $10…
then at $20…
then at $30…
They’ll be back at $300 pretending they knew all along.
Ignore the noise.
Know what you own.
Big moment for #GEO! Thrilled to confirm DDH1 is mobilising for our maiden drill campaign at Juno 🇦🇺—same elite crew that kicked off Havieron.
This marks the start of a transformational period for our company. If successful, the potential for immense shareholder value is real 😁
$LUMN insiders are stepping in.
- On Aug 15, CFO Christopher Stansbury bought 40,000 shares at $4.44
- A $177.6K purchase, boosting his stake by 8.08% to 535,000 shares ($2.38M)
- Both the CEO and CFO have been buying on the open market between $3.69–$4.43
- They sell for many reasons but they BUY for just one
Let’s go $LUMN
$PRME
Sitting on $260M in cash.
Runway into 2027 without needing another offering. That includes proceeds from the recent raise + $6M from the CF Foundation.
Collab funding still TBD. FDA catalysts likely by Q4. Read the ER.
With their platform + pipeline, this is a no-brainer.
Under $5 now… $10–$20 in a year isn’t crazy.
The only certainty I know is I don’t own enough $PRME 👀
$PRME
Ask yourself why the big players want your shares so badly
2025 isn’t just another year
it’s a defining moment for this tech
David Liu isn’t loading up for no reason.
Turning point.
https://t.co/nUR06Jhfuu
#Women have been conditioned to fear meat and fat
Taught that salads with no protein are healthier and more “feminine”
But this mindset is making us sick
Meat isn’t just for men—it’s essential for our health, hormones, and fertility.
Eat the steak. And the fat. Thrive.
$PRME – Looks like a $500M deal between Harvard and the Trump admin is almost done (via Morning Joe). Once it lands, billions in funding, patents, and cures could be unlocked.
This is the setup.
Catalyst in play.
$PRME could pop in the next 30 days
Received a photo of a dozer at Telfer last week. From the logo RJV, I did a bit of tracking and found this. If you’re into the nuts & bolts like me you may be interested in the TSF8 upgrade.
#GGP#Telfer
https://t.co/oOrdOClEsC